# US 2025/0144274 A1 · Boron carbon nitride (bcn) nanocoatings on central venous catheters inhibit bacterial colonization

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144274 A1
- Document ID: US20250144274A1
- Status: Published application
- Kind: A1
- Application number: 19/015,146
- Filed: 2025-01-09
- Published: 2025-05-08
- Earliest claimed: 2021-03-10
- Assignees: University of Central Florida Research Foundation, Inc.
- Applicants: University of Central Florida Research Foundation, Inc.
- Inventors: Kalpathy B. Sundaram; Varsha Naga; Shraddha Dhanraj Nehate; Ashwin Kumar Saikumar
- Web page: https://patentgrep.com/patent/US20250144274A1

## CPC

- A61L 29/106: {Inorganic materials other than carbon}
- A61L 29/04: Macromolecular materials
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2420/02: Methods for coating medical devices
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A novel anti-microbial coating and uses thereof on medical devices are presented. The novel coating is comprised of a layer of boron carbon nitride (BCN) coated onto a medical device such as a catheter. The BCN coating was found to inhibit bacterial growth by at least 80% and reduce biofilm formation by at least 60% on the treated surface of the catheter. This coating can be used to reduce or prevent central line associated bloodstream infections (CLABSI) in patients as well as inhibit bacterial growth and biofilm formation on a variety of medical devices or polymeric surfaces.

## Claims

### Claim 1

A method of inhibiting bacterial growth and biofilm formation on a polymeric surface comprising:
applying a boron carbon nitride (BCN) nano-coating onto at least a portion of the polymeric surface;
wherein the BCN nano-coating inhibits the bacterial growth and biofilm formation on the polymeric surface.

### Claim 2 (depends on 1)

The method of claim 1, wherein the BCN nano-coating is applied to the polymeric surface of a medical device.

### Claim 3 (depends on 2)

The method of claim 2, wherein the medical device is a catheter.

### Claim 4 (depends on 1)

The method of claim 1, wherein the BCN nano-coating is applied to the polymeric surface by RF magnetron sputtering.

### Claim 5 (depends on 4)

The method of claim 4, wherein base pressure of a deposition chamber for the RF magnetron sputtering is 4×10−7 Torr.

### Claim 6 (depends on 5)

The method of claim 5, wherein the BCN nano-coating is applied to the catheter at a fixed pressure of 5 mTorr in presence of N2/A (0.25) while maintaining total gas flow at 20 sccm.

### Claim 7 (depends on 6)

The method of claim 6, wherein RF power to the boron carbide source material is set at 200 W.

### Claim 8 (depends on 1)

The method of claim 1, wherein the nano-coating is between about 60-100 nm in thickness.

### Claim 9 (depends on 1)

The method of claim 1, wherein the nano-coating has a surface roughness between about 80-120 nm.

### Claim 10 (depends on 1)

The method of claim 1, wherein gram-negative, gram-positive, or a combination thereof of the bacterial growth is inhibited.

### Claim 11 (depends on 1)

The method of claim 1, wherein at least 80% of the bacterial growth on the surface of the polymeric surface is inhibited.

### Claim 12 (depends on 1)

The method of claim 1, wherein the biofilm formation on the polymeric surface is reduced by at least 60%.

### Claim 13

A method of reducing or preventing central line associated bloodstream infections (CLABSI) in a patient comprising:
inserting a central venous catheter into the patient wherein the central venous catheter is coated with a boron carbon nitride (BCN) nano-coating on at least a portion of an inner surface of the central venous catheter, on at least a portion of an outer surface of the central venous catheter, or on at least a portion of both the inner and the outer surfaces of the central venous catheter;
wherein the BCN nano-coating inhibits microbial adhesion and biofilm formation on the surface of the central venous catheter to reduce CLABSI in the patient.

### Claim 14 (depends on 13)

The method of claim 13, wherein the nano-coating is between about 60-100 nm in thickness.

### Claim 15 (depends on 13)

The method of claim 13, wherein the nano-coating has a surface roughness between about 80-120 nm.
